Interaction of FGF9 with FGFR3‐IIIb/IIIc, a putative driver of growth and aggressive behaviour of hepatocellular carcinoma
Author:
Affiliation:
1. Department of Medicine I Division: Institute of Cancer Research Comprehensive Cancer Center Vienna Medical University of Vienna Vienna Austria
Publisher
Wiley
Subject
Hepatology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14505
Reference28 articles.
1. Global trends and predictions in hepatocellular carcinoma mortality
2. Systemic therapy for intermediate and advanced hepatocellular carcinoma: Sorafenib and beyond
3. Molecular therapies and precision medicine for hepatocellular carcinoma
4. Fibroblast growth factor family as a potential target in the treatment of hepatocellular carcinoma;Coleman SJ;J Hepatocell Carcinoma,2014
5. Dysregulated FGF signalling in neoplastic disorders
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Signaling pathways in liver cancer: pathogenesis and targeted therapy;Molecular Biomedicine;2024-05-31
2. Differentiated and non-differentiated HepaRG™ cells: A possible in-vitro model system for early hepatocarcinogenesis and non-genotoxic carcinogens;Toxicology Letters;2023-12
3. FGFR families: biological functions and therapeutic interventions in tumors;MedComm;2023-09-23
4. FGF9 Recruits β‐Catenin to Increase Hepatic ECM Synthesis and Promote NASH‐Driven HCC;Advanced Science;2023-08-11
5. Protein Interactome Profiling of Stable Molecular Complexes in Biomaterial Lysate;International Journal of Molecular Sciences;2022-12-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3